Lactic acidosis in HIV-1 infected patients receiving antiretroviral therapy

Journal of Association of Physicians of India

Volumn 52, Issue AUG, 2004, Pages 666-669

  Patel, A K ^a   Patel, K ^a   Patel, J ^b  

^a Sterling Hospital   (India)

^b Adit Diagnostic Center   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG COMBINATION; EPIDEMIOLOGY; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; LACTIC ACIDOSIS; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; RISK ASSESSMENT;

ACIDOSIS, LACTIC; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; INDIA; MALE; MIDDLE AGED; RISK ASSESSMENT; SAMPLING STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 18744390070     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. White AJ. Mitochondrial toxicity and HIV therapy. Sex Transm Infect 2001;77:158-73.
2. Brinkman K, Kakuda TN. Mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors: a looming obstacle for long-term antiretroviral therapy? Curr Opin Infect Dis 2000;13:5-11.
3. Walker UA, Setzer B, Venhoff N. Increased long-term mitochondrial toxicity in pyrimidine nucleoside combinations. In: Program and Abstracts of the 3rd International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV; October 23-26, 2001; Athens, Greece. Abstract 18.
4. John M, Mallal S. Hyperlactatemia syndromes in people with HIV infection. Curr Opin Infect Dis 2002; 15:23-9.
5. Gérard Y, Maulin L, Yazdanpanah Y, et al. Symptomatic hyperlactatemia: an emerging complication of antiretroviral therapy. AIDS 2000;14:2723-30.
6. Delgado J, Harris M, Tesiorowski A, et al. Symptomatic elevations of lactic acid and their response to treatment manipulation in human immunodeficiency virus-infected persons: a case series. Clin Infect Dis 2001;33:2072-4.
7. Marcus K, Truffa M, Boxwell D, et al. Recently identified adverse events secondary to NRTI therapy in HIV-infected individuals: cases from the FDA's Adverse Event Reporting System (AERS). In: Program and Abstracts of the 9th Conference on Retroviruses and Opportunistic Infections; February 22-25, 2002; Seattle. Abstract LB14.
8. Coghlan ME, Sommadossi JP, Jhala NC, et al. Symptomatic lactic acidosis in hospitalized antiretroviral-treated patients with human immunodeficiency virus infection: a report of 12 cases. Clin Infect Dis 2001;33:1914-21.
9. Brew B, Tisch S, Law M. Lactate concentrations distinguish between nucleoside neuropathy and HIV distal symmetrical sensory polyneuropathy. In: Program and Abstracts of the 8th Conference on Retroviruses and Opportunistic Infections; February 4-8, 2001; Chicago. Abstract 9.
10. Mokrzycki MH, Harris C, May H, et al. Lactic acidosis associated with stavudine administration: a report of five cases. Clin Infect Dis 2000;30:198-200.
11. Lenzo NP, Garas BA, French MA. Hepatic steatosis and lactic acidosis associated with stavudine treatment in an HIV patient: a case report. AIDS 1997;11:1294-1296.
12. Falcó V, Rodriguez D, Ribera E, et al. Severe nucleoside- associated lactic acidosis in human immunodeficiency virus-infected patients: report of 12 cases and review of the literature. Clin Infect Dis 2002;34:838-46.
13. Boubaker K, Flepp M, Sudre P, et al. Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study. Clin Infect Dis 2001;33:1931-7.